17 May 2023 | News
To further develop a suite of oral microbiome & human genes expression tests
image credit- shutterstock
New Delhi-based startup Genefitletics, a direct-to-consumer microbiome company, pioneering application of microbial technologies to save human health, has raised an undisclosed amount at pre money valuation of Rs.7.5 crore from a group of Angels.
The startup is working on breakthrough discoveries in microbial science, to bridge the gap between scientific advancements and human health. The company’s unique platform- PROTEBA, works at the convergence of microbial sequencing, artificial intelligence & scientific research to develop pipeline of consumer health solutions, precision diagnostics & precision bio therapeutics for promoting better health and longevity .
Genefitletics conducts at-home direct-to-customer gut and vaginal microbiome tests. The process includes collecting biological data from an individual’s biological sample, to analyse human microbial functions at molecular level, and provide category defining interventions to regulate an individual’s biology.
The company plans to deploy these funds to further develop a suite of oral microbiome & human genes expression tests as well as launch its own brand of precision biotics. The funds will also be used to further develop machine learning models for human biology, to decode root cause of poor health.
Genefitletics was incubated at IIM Udaipur Incubation centre & is also part of Leap to Unicorn bootcamp programme- an initiative by IDFC FIRST Bank, in association with Money control and CNBCTV18.